Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: Effects of hormonal contraception, pregnancy, and vitamin A deficiency

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 58-63

  Mostad, Sara B ^a   Kreiss, Joan K ^a   Ryncarz, Alexander J ^a,b   Mandaliya, Kishorchandra ^c   Chohan, Bhavna ^d   Ndinya Achola, Jeckoniah ^d   Bwayo, Job J ^d   Corey, Lawrence ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Department of Obstetrics and Gynaecology   (Kenya)

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; FEMALE; HERPES SIMPLEX VIRUS; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RETINOL DEFICIENCY; SEROPREVALENCE; SEXUAL TRANSMISSION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS SHEDDING;

CERVIX UTERI; CONTRACEPTION; CONTRACEPTIVES, ORAL, HORMONAL; CROSS-SECTIONAL STUDIES; FEMALE; HERPES SIMPLEX; HIV SEROPOSITIVITY; HIV-1; HUMANS; KENYA; PREGNANCY; VIRUS SHEDDING; VITAMIN A DEFICIENCY;

EID: 0033972358     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315188     Document Type: Article

References (34)

1. 1. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990;69:19-36.
2. 2. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
3. 3. Siegel D, Golden E, Washington E, et al. Prevalence and correlates of herpes simplex infections: the population-bases AIDS in multiethnic neighborhoods study. JAMA 1992;268:1702-08.
4. 4. Beyrer C, Jitwatcharanan K, Natpratan C, et al. Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. J Infect Dis 1998;178:243-6.
5. 5. Morse SA, Trees DL, Htun Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genial ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis 1997;175:583-9.
6. 6. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
7. 7. Brown ZA, Benedetti J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. New Engl J Med 1991;324:1247-52.
8. 8. Wald A, Zeh J, Selke S, Ashley R, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. New Engl J Med 1995;333:770-75.
9. 9. Brock B, Selke S, Benedetti J, Douglas JM, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 1990;263:418-20.
10. 10. Koelle DM, Benedetti J, Langenber A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992;116:433-7.
11. 11. Brown, ZA, Vontver LA, Benedetti J, et al. Genital herpes in pregnancy: risk factors associated with recurrences and asymptomatic viral shedding. Am J Obstet Gynecol 1985;153:24-30.
12. 12. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women, effect of acyclovir treatment. J Clin Invest 1997;99:1092-7.
13. 13. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995;123:845-7.
14. 14. Hitti J, Watts DH, Burchett SK, et al. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 1997;177:450-4.
15. 15. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;350:922-7.
16. 16. Ryncarz A, Goddard J, Wald A, Corey L, Roizman B. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol 1999;37:1941-7.
17. 17. Semba RD. Vitamin A, immunity, and infection. Clin Infect Dis 1994;19: 489-99.
18. 18. Sommer A, West KP. Vitamin A deficiency: health, survival, and vision. New York: Oxford University Press, 1996:84-8, 299-324.
19. 19. Amatayakul K. Metabolism: vitamins and trace elements. In: Pharmacology of the contraceptive steroids. Goldzieher J, ed. New York: Raven Press, 1994:363-77.
20. 20. Mishell DR, Thomeycroft IH, Nakamura RM, Nagata Y, Stone SC. Serum estradiol in women ingesting combination oral contraceptive steroids. Am J Obstet Gynecol 1972;114:923-8.
21. 21. Oritz A, Hiroi M, Stanczyk FZ, Goebelsmann U, Mishell DR. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. J Clin Endocrinol Metab 1977;44:32-8.
22. 22. Speroff L, Darney P. A clinical guide for contraception, 2d ed. Baltimore: Williams and Wilkins, 1996:25-117.
23. 23. Mostad SB. Prevalence and correlates of HIV type 1 shedding in the female genital tract. AIDS Res Hum Retroviruses 1998;14(Suppl 1):S11-S15.
24. 24. Strahle U, Klock G, Schutz G. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci USA 1987;84:7871-5.
25. 25. Harger JH, Pazin GJ, Breinig MC. Current understanding of the natural history of genital herpes simplex infections. J Reprod Med 1986;31(Suppl 5):365-73.
26. 26. Sonnex C. Influence of ovarian hormones on urogenital infection. Sex Transm Infect 1998;74:11-19.
27. 27. Baker DA, Phillips CA, Roessner K, Albertini, RJ, Mann LI. Suppression by progesterone of nonspecific in vitro lymphocyte stimulation in mice as a mechanism for the enhancement of herpes simplex virus type 2 vaginal infection. Am J Obstet Gynecol 1980;136:440-5.
28. 28. Bujko M, Sulovic V, Zivanovic V, Lako B, Dotlic R. Effect of progesterone and pregnancy on the replication of herpes simplex virus type 2 in vivo. Clin Exp Obset Gynecol 1988;15:34-37.
29. 29. Brown ZA, Vontver LA, Benedetti J, et al. Genital herpes in pregnancy: Risk factors associated with recurrences and asymptomatic viral shedding. Am J Obstet Gynecol 1985;153:24-30.
30. 30. Harger JH, Amortegui AJ, Meyer MP, Pazin GJ. Characteristics of recurrent genital herpes simplex infections in pregnant women. Obstet Gynecol 1989;73:367-72.
31. 31. Frenkel LM, Garratty EM, Shen JP, Wheeler N, Clark O, Bryson YJ. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993;118: 414-18.
32. 32. Isaacs CE, Kascsak R, Pullarkat RK, Xu W, Schneidman K. Inhibition of herpes simplex virus replication by retinoic acid. Antiviral Res 1997; 33: 117-27.
33. 33. Nauss KM, Anderson CA, Conner MW, Newberne PM. Ocular infection with herpes simplex virus (HSV-1) in vitamin A deficient and control rats. J Nutr 1985;115:1300-15.
34. 34. Smolin G, Okumoto M, Friedlaender M, Kwok S. Herpes simplex keratitis treatment with vitamin A. Arch Ophthalmol 1979;97:2181-3.